Showing 3951-3960 of 19385 results for "".
Gaps in Shingles Vaccination: What Clinicians Need to Know
https://reachmd.com/programs/vaccination/gaps-shingles-vaccination/54087/While shingles poses a significant but preventable threat for older and immunocompromised adults, vaccination rates remain critically low. To help address this concerning gap in care, this brief video explores how we can identify eligible patients, confidently recommend vaccination, and incorporateExploring the Gut-Skin Axis in Psoriasis
https://reachmd.com/programs/Audioabstracts/gut-skin-axis-psoriasis/39683/Psoriasis may present on the skin, but emerging evidence suggests its inflammatory roots extend deep into the gut. In this AudioAbstract, Ryan Quigley reviews findings from a comprehensive article published in Frontiers in Microbiology, examining how microbial dysbiosis, impaired barrier integrity,Multiplex Proteomic Biomarkers in MS: Emerging Tools for Precision Care
https://reachmd.com/programs/neurofrontiers/multiplex-proteomic-biomarkers-ms/54239/Multiplex proteomic biomarker panels are redefining how we understand and monitor multiple sclerosis (MS) by capturing interconnected pathways in a single sample. Hear from Dr. Raphael Schneider as he explores how these tools could inform prognosis, risk stratification, and clinical trial design, whUnderstanding Accelerated Biological Aging in Pediatric MS
https://reachmd.com/programs/neurofrontiers/accelerated-biological-aging-pediatric-ms/54240/Emerging evidence shows that children with multiple sclerosis exhibit accelerated biological aging. Learn more about the potential implications with Dr. Jennifer Yang, who spoke about this topic at the 2026 ACTRIMS Forum. She's an Assistant Professor of Neurosciences at the UC San Diego School of MeRecognizing When to Escalate Therapy in Atopic Dermatitis Care
https://reachmd.com/programs/dermconsult/escalating-therapy-atopic-dermatitis/49019/Identifying when to escalate therapy in atopic dermatitis can be challenging when standard scoring tools don't capture the full patient burden. However, combining clinical insights with patient-reported outcomes like itch, pain, and sleep disruption can help guide timely systemic treatment decisionsUnderstanding Crossover and Endpoints in ASCENT-03 and -04
https://reachmd.com/programs/project-oncology/crossover-endpoints-ascent-03-04/48951/Knowing how crossover affects efficacy endpoints is key in interpreting clinical trial data for metastatic triple-negative breast cancer. The ASCENT-03 and -04 trials, which allowed crossover and tested sacituzumab govitecan in the first-line setting, offer insights into the limitations of overall sThe Future of Customized Treatments Within the Atopic Dermatitis Pipeline
https://reachmd.com/programs/dermatology-hub-neuroimmune-network/the-future-of-customized-treatments-within-the-atopic-dermatitis-pipeline/37165/Practical Dermatology Editorial Board member Peter Lio, MD, a Clinical Assistant Professor of Dermatology and Pediatrics at Northwestern University Feinberg School of Medicine, discusses the potential impact of new developments in atopic dermatitis research.Beyond the Cure: Addressing Psychosocial Needs in Gene Therapy for SCD
https://reachmd.com/programs/project-oncology/psychosocial-needs-gene-therapy-scd/39974/Gene therapy offers transformative potential for individuals with sickle cell disease, but the psychosocial challenges that accompany such a major decision are often underestimated. Hear from Dr. Victoria Coleman-Cowger as she highlights recommendations for supporting emotional wellbeing during andObesity and Cancer Screening: National Trends and Disparities Revealed
https://reachmd.com/programs/clinicians-roundtable/obesity-and-cancer-screening-national-trends-and-disparities-revealed/39649/Emerging data reveal a troubling trend: individuals with higher body mass index are significantly less likely to receive routine cancer screenings, raising urgent concerns about care equity. Join Dr. Vance Albaugh, Assistant Professor of Metabolic Surgery at Pennington Biomedical Research CenterAdvances in COVID-19 Protection: A Look at the mRNA-1283 Vaccine
https://reachmd.com/programs/clinicians-roundtable/advances-in-covid-19-protection-a-look-at-the-mrna-1283-vaccine/36420/The mRNA-1283 COVID-19 vaccine is a next-generation approach to immunization, focusing the immune response on key components of the SARS-CoV-2 spike protein. By targeting both the receptor-binding and N-terminal domains, this vaccine aims to enhance the potency and durability of neutralizing antibod